Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. Cash on Hand 2020–2025
Xeris Biopharma Holdings, Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Xeris Biopharma Holdings, Inc. cash on hand as of December 31, 2025: 111.0M, a 55.04% increase year-over-year.
- Xeris Biopharma Holdings, Inc. cash on hand for 2025 were 111.0M, a 55.04% increase from 2024.
- Xeris Biopharma Holdings, Inc. cash on hand for 2024 were 71.6M, a 6.19% increase from 2023.
- Xeris Biopharma Holdings, Inc. cash on hand for 2023 were 67.4M, a 44.70% decrease from 2022.
- Xeris Biopharma Holdings, Inc. cash on hand for 2022 were 122.0M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Xeris Biopharma Holdings, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $111 |
| 2024 | $72 |
| 2023 | $67 |
| 2022 | $122 |
| 2021 | $67 |
| 2020 | $38 |
Xeris Biopharma Holdings, Inc. Cash on Hand — FAQ
Xeris Biopharma Holdings, Inc. (XERS) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's cash on hand history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s cash on hand by year and by quarter, including the growth rate.